CN103044515B - A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis - Google Patents
A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis Download PDFInfo
- Publication number
- CN103044515B CN103044515B CN201210569717.9A CN201210569717A CN103044515B CN 103044515 B CN103044515 B CN 103044515B CN 201210569717 A CN201210569717 A CN 201210569717A CN 103044515 B CN103044515 B CN 103044515B
- Authority
- CN
- China
- Prior art keywords
- hopenen
- diols
- beta
- ethyl acetate
- volume ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 241001661277 Moelleriella libera Species 0.000 title claims abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 49
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000001953 recrystallisation Methods 0.000 claims abstract description 6
- 239000000741 silica gel Substances 0.000 claims abstract description 6
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 229960001866 silicon dioxide Drugs 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 230000003068 static effect Effects 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 5
- 238000002390 rotary evaporation Methods 0.000 claims description 5
- 229930000044 secondary metabolite Natural products 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 239000002207 metabolite Substances 0.000 abstract description 4
- 239000012141 concentrate Substances 0.000 abstract description 3
- 239000000287 crude extract Substances 0.000 abstract 2
- -1 extraction Substances 0.000 abstract 1
- 241000258937 Hemiptera Species 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000010183 spectrum analysis Methods 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- YARKUPNYWCQHFO-UHFFFAOYSA-N Dustanin Natural products C12CCC3C4(C)CCCC(C)(C)C4CCC3(C)C1(C)C(O)CC1C2(C)CCC1C(C)(O)C YARKUPNYWCQHFO-UHFFFAOYSA-N 0.000 description 1
- 241000221775 Hypocreales Species 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- YARKUPNYWCQHFO-ZUXTZSAESA-N dustanin Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)[C@@H](O)C[C@@H]1[C@]3(C)CC[C@@H]1C(C)(O)C YARKUPNYWCQHFO-ZUXTZSAESA-N 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种从粉虱座壳孢菌中提取17(21)-何帕烯-6,12β-二醇的方法。 The invention relates to a method for extracting 17(21)-hoppene-6,12β-diol from Secospora whitefly.
背景技术 Background technique
粉虱座壳孢菌(Aschersonia aleyrodis)隶属于子囊菌门、粪菌纲、肉座菌目、麦角菌科、座壳孢属,是一种重要虫生真菌,主要寄生于粉虱,其孢子具有较强的杀粉虱活性,并已制成商品化的杀虫剂,代谢产物也具有杀粉虱、蚜虫等活性,并具有广谱抑菌性,而且代谢产物不受季节、温度、雨水等影响,具有较好的应用前景。 Aschersonia aleyrodis belongs to Ascomycota, Copromycetes , Hypocreales, Ergotaceae, Ascheria genus, is an important entomogenic fungus, mainly parasitic on whitefly, its spores It has strong whitefly killing activity and has been made into a commercial insecticide. The metabolites also have activities such as killing whitefly and aphids, and have broad-spectrum antibacterial properties, and the metabolites are not affected by seasons, temperature, and rain. And so on, has a good application prospect.
随着对该菌的逐步研究,人们已从其代谢产物中分离出一些化合物并具有一定活性,如三萜类物质泽喔萜、杜斯塔宁具有抗结核杆菌的活性,蒽醌类物质细皱青霉素、醌莃素具有细胞毒活性,17(21)-何帕烯-6,12β-二醇是五元环三萜类物质,分子式C30H50O2,具有抗疟原虫活性,IC50为15μM,该物质具有潜在的医药价值。 With the gradual research on the bacterium, some compounds have been isolated from its metabolites and have certain activities, such as triterpenoids zeoxaline and dustanin have anti-tuberculosis activity, anthraquinones fine Penicillin and quinone acanthin have cytotoxic activity, 17(21)-hoppene-6,12β-diol is a five-membered ring triterpenoid with molecular formula C 30 H 50 O 2 , has anti-plasmodium activity, IC 50 is 15μM, the substance has potential medical value.
发明内容 Contents of the invention
本发明的目的是公开一种从粉虱座壳孢菌中提取17(21)-何帕烯-6,12β-二醇{17(21)-hopene-6,12β-diol}的方法,以促进医药领域的研究和开发。 The object of the present invention is to disclose a method for extracting 17(21)-hopene-6,12β-diol {17(21)-hopene-6,12β-diol} from Ascospora whitefly, with To promote research and development in the field of medicine.
本发明的技术方案: Technical scheme of the present invention:
本发明公开一种从粉虱座壳孢菌中提取17(21)-何帕烯-6,12β-二醇的方法,包括如下步骤: The invention discloses a method for extracting 17(21)-hoppene-6,12β-diol from Ascospora whitefly, comprising the following steps:
1) 粉虱座壳孢菌活化后(邱君志等,昆虫病原真菌粉虱座壳孢对烟粉虱侵染行为的初步研究. 菌物学报,2004,23(1):115~121),取菌块接种到M102培养基中,在120~160r/min、20~28℃条件下连续培养5~10天即初级培养,按8%~10%接种量再次转接到M102培养基中,在20~28℃条件下静止培养30~40天即次级代谢产物。 1) After activation of Ascospora whitefly (Qiu Junzhi et al., Preliminary study on the infestation behavior of the entomopathogenic fungus Ascospora whitefly to whitefly whitefly. Acta Mycophyta Sinica, 2004, 23(1):115~121), taken from Bacterial blocks were inoculated into M102 medium, cultured continuously for 5-10 days under the conditions of 120-160r/min, 20-28°C, namely primary culture, and then transferred to M102 medium again according to 8%-10% inoculum amount. The secondary metabolites can be obtained after static culture at 20-28°C for 30-40 days.
2) 菌液和菌丝体过滤分离,菌丝体:甲醇体积比=1: 5~10浸泡24~48小时,浸泡液旋蒸浓缩至干,回收甲醇,用一倍菌丝体体积的水溶解旋干物,将水溶物与乙酸乙酯按体积比1:1~1:3进行摇瓶萃取,摇30~60min静止30~60min,将乙酸乙酯部分浓缩得浸膏。 2) Bacterial liquid and mycelium are filtered and separated, mycelium: methanol volume ratio = 1: 5~10, soaked for 24~48 hours, the soaking solution is concentrated to dryness by rotary evaporation, methanol is recovered, and water with one volume of mycelium is used Dissolve the spin-dried product, extract the water-soluble product and ethyl acetate at a volume ratio of 1:1~1:3 in a shaker flask, shake for 30~60 minutes and stand still for 30~60 minutes, then concentrate part of the ethyl acetate to obtain an extract.
3) 浸膏上200~300目硅胶柱,以石油醚:乙酸乙酯体积比70:1到1:1梯度洗脱,合并体积比20:1到15:1的洗脱液,自然挥干,利用重结晶得17(21)-何帕烯-6,12β-二醇。 3) Put the extract on a 200-300-mesh silica gel column, elute with a gradient of petroleum ether:ethyl acetate volume ratio of 70:1 to 1:1, combine the eluent with a volume ratio of 20:1 to 15:1, and evaporate to dry naturally , 17(21)-Hoppene-6,12β-diol was obtained by recrystallization.
所述M102培养基的制备方法如下,取蔗糖 30g,麦芽提取物 20 g,蛋白胨 2.0 g,酵母提取物 1.0 g,KCl 0.5 g,MgSO4 0.5 g,KH2PO4 0.5 g,混匀后加单蒸水定容至1L,分装到250ml三角瓶中,每瓶装100ml,在121℃高压下灭菌20min。 The preparation method of the M102 medium is as follows, take 30 g of sucrose, 20 g of malt extract, 2.0 g of peptone, 1.0 g of yeast extract, 0.5 g of KCl, 0.5 g of MgSO 4 , 0.5 g of KH 2 PO 4 , mix well and add Distilled water to 1L, divided into 250ml Erlenmeyer flasks, 100ml per bottle, sterilized at 121℃ for 20min under high pressure.
所述17(21)-何帕烯-6,12β-二醇的结构式如下(分子式C30H50O2): The structural formula of the 17(21)-hoppene-6,12β-diol is as follows (molecular formula C 30 H 50 O 2 ):
本发明的显著优点: Significant advantage of the present invention:
1) 取材方便 1) It is convenient to obtain materials
2) 过程简单、易操作 2) The process is simple and easy to operate
3) 成本低、纯度高。 3) Low cost and high purity.
4) 促进医药领域对的17(21)-何帕烯-6,12β-二醇的研究和开发。 4) Promote the research and development of 17(21)-Hoppene-6,12β-diol in the field of medicine.
附图说明 Description of drawings
图1为17(21)-何帕烯-6,12β-二醇的氢谱; Fig. 1 is the hydrogen spectrum of 17(21)-hopene-6,12β-diol;
图2为17(21)-何帕烯-6,12β-二醇的碳谱。 Figure 2 is the carbon spectrum of 17(21)-hoppene-6,12β-diol.
具体实施方式 Detailed ways
以下各实施例中M102培养基的制备方法如下:取蔗糖 30g,麦芽提取物 20 g,蛋白胨 2.0 g,酵母提取物 1.0 g,KCl 0.5 g,MgSO4 0.5 g,KH2PO4 0.5 g,混匀后加单蒸水定容至1L,分装到250ml三角瓶中,每瓶装100ml,在121℃高压下灭菌20min。 The preparation method of M102 medium in the following examples is as follows: take 30 g of sucrose, 20 g of malt extract, 2.0 g of peptone, 1.0 g of yeast extract, 0.5 g of KCl, 0.5 g of MgSO 4 , 0.5 g of KH 2 PO 4 , and mix After homogeneity, add distilled water to make it up to 1L, divide into 250ml Erlenmeyer flasks, each bottle contains 100ml, and sterilize under high pressure at 121°C for 20min.
实施例1Example 1
1) 粉虱座壳孢菌活化后,取菌块接种到M102培养基中,在150r/min、25℃条件下连续培养8天即初级培养,按9%接种量再次转接到M102培养基中,在25℃条件下静止培养38天即得次级代谢产物。 1) After the activation of Ascospora whitefly, take the bacterial block and inoculate it into the M102 medium, and cultivate it continuously for 8 days under the conditions of 150r/min and 25°C, which is the primary culture, and transfer it to the M102 medium again according to the inoculation amount of 9%. Secondary metabolites were obtained by static culture at 25°C for 38 days.
2) 菌液和菌丝体过滤分离,菌丝体:甲醇体积比=1: 8浸泡36小时,浸泡液旋蒸浓缩至干,回收甲醇,用一倍菌丝体体积的水溶解旋干物,将水溶物与乙酸乙酯按体积比1:2.5进行摇瓶萃取,摇50min静止50min,将乙酸乙酯部分浓缩得浸膏。 2) Bacterial liquid and mycelium were separated by filtration, mycelium: methanol volume ratio = 1: 8 soaked for 36 hours, the soaking liquid was concentrated to dryness by rotary evaporation, methanol was recovered, and the spin-dried product was dissolved in water with one volume of mycelium. Extract the water-soluble matter and ethyl acetate in a shaker flask at a volume ratio of 1:2.5, shake for 50 minutes and rest for 50 minutes, and concentrate the ethyl acetate part to obtain the extract.
3) 浸膏上200~300目硅胶柱,以石油醚:乙酸乙酯体积比70:1到1:1梯度洗脱,合并体积比20:1到15:1的洗脱液,自然挥干,利用重结晶得17(21)-何帕烯-6,12β-二醇产物。 3) Put the extract on a 200-300-mesh silica gel column, elute with a gradient of petroleum ether:ethyl acetate volume ratio of 70:1 to 1:1, combine the eluent with a volume ratio of 20:1 to 15:1, and evaporate to dry naturally , 17(21)-Hoppene-6,12β-diol product was obtained by recrystallization.
提取率%=纯17(21)-何帕烯-6,12β-二醇重量/浸膏总量×100%=4.18%。 Extraction rate% = weight of pure 17(21)-hopaene-6,12β-diol/total amount of extract x 100%=4.18%.
对上述重结晶产物进行氢谱、碳谱分析,上述重结晶17(21)-何帕烯-6,12β-二醇的氢谱、碳谱见图1、图2,验证了该物质即为17(21)-何帕烯-6,12β-二醇。 The hydrogen spectrum and carbon spectrum analysis of the above-mentioned recrystallized product are carried out. The hydrogen spectrum and carbon spectrum of the above-mentioned recrystallized 17(21)-Hoppene-6,12β-diol are shown in Fig. 1 and Fig. 2, which proves that the substance is 17(21)-Hoppene-6,12β-diol.
实施例2Example 2
1) 粉虱座壳孢菌活化后,取菌块接种到M102培养基中,在120r/min、20℃条件下连续培养5天即初级培养,按8%接种量再次转接到M102培养基中,在20℃条件下静止培养30天即得次级代谢产物。 1) After activation of Ascospora whitefly, take the bacterial block and inoculate it into the M102 medium, and cultivate it continuously for 5 days under the conditions of 120r/min and 20°C, which is the primary culture, and transfer it to the M102 medium again according to the inoculation amount of 8%. Secondary metabolites were obtained by static culture at 20°C for 30 days.
2) 菌液和菌丝体过滤分离,菌丝体:甲醇体积比=1:5浸泡24小时,浸泡液旋蒸浓缩至干,回收甲醇,用一倍菌丝体体积的水溶解旋干物,将水溶物与乙酸乙酯按体积比1:1进行摇瓶萃取,摇30min静止30min,将乙酸乙酯部分浓缩得浸膏。 2) Bacterial liquid and mycelium are filtered and separated, mycelium: methanol volume ratio = 1:5 and soaked for 24 hours, the soaking solution is concentrated to dryness by rotary evaporation, methanol is recovered, and the spin-dried product is dissolved in water with one volume of mycelium. The water-soluble matter and ethyl acetate were extracted in a shaker flask at a volume ratio of 1:1, shaken for 30 minutes and stood still for 30 minutes, and the ethyl acetate was partially concentrated to obtain an extract.
3) 浸膏上200~300目硅胶柱,以石油醚:乙酸乙酯体积比70:1到1:1梯度洗脱,合并体积比20:1到15:1的洗脱液,自然挥干,利用重结晶得17(21)-何帕烯-6,12β-二醇产物。 3) Put the extract on a 200-300 mesh silica gel column, elute with a gradient of petroleum ether:ethyl acetate volume ratio of 70:1 to 1:1, combine the eluent with a volume ratio of 20:1 to 15:1, and evaporate to dryness naturally , 17(21)-Hoppene-6,12β-diol product was obtained by recrystallization.
提取率%=纯17(21)-何帕烯-6,12β-二醇重量/浸膏总量×100%=3.32%。 Extraction rate% = weight of pure 17(21)-hopaene-6,12β-diol/total amount of extract × 100% = 3.32%.
对上述重结晶产物进行氢谱、碳谱分析,上述重结晶17(21)-何帕烯-6,12β-二醇的氢谱、碳谱见图1、图2,验证了该物质即为17(21)-何帕烯-6,12β-二醇。 The hydrogen spectrum and carbon spectrum analysis of the above-mentioned recrystallized product are carried out. The hydrogen spectrum and carbon spectrum of the above-mentioned recrystallized 17(21)-Hoppene-6,12β-diol are shown in Fig. 1 and Fig. 2, which proves that the substance is 17(21)-Hoppene-6,12β-diol.
实施例3Example 3
1) 粉虱座壳孢菌活化后,取菌块接种到M102培养基中,在160r/min、28℃条件下连续培养10天即初级培养,按10%接种量再次转接到M102培养基中,在28℃条件下静止培养40天即得次级代谢产物。 1) After activation of Ascospora whitefly, take the bacterial block and inoculate it into the M102 medium, and culture it continuously for 10 days under the conditions of 160r/min and 28°C, which is the primary culture, and transfer it to the M102 medium again according to 10% inoculum amount Secondary metabolites were obtained by static culture at 28°C for 40 days.
2) 菌液和菌丝体过滤分离,菌丝体:甲醇体积比=1:10浸泡48小时,浸泡液旋蒸浓缩至干,回收甲醇,用一倍菌丝体体积的水溶解旋干物,将水溶物与乙酸乙酯按体积比1:3进行摇瓶萃取,摇60min静止60min,将乙酸乙酯部分浓缩得浸膏。 2) Bacterial liquid and mycelium were separated by filtration, mycelium: methanol volume ratio = 1:10 and soaked for 48 hours, the soaking liquid was concentrated to dryness by rotary evaporation, methanol was recovered, and the spin-dried product was dissolved in water with one volume of mycelium. The water-soluble matter and ethyl acetate were extracted in a shaker flask at a volume ratio of 1:3, shaken for 60 minutes and rested for 60 minutes, and the ethyl acetate was partially concentrated to obtain an extract.
3) 浸膏上200~300目硅胶柱,以石油醚:乙酸乙酯体积比70:1到1:1梯度洗脱,合并体积比20:1到15:1的洗脱液,自然挥干,利用重结晶得17(21)-何帕烯-6,12β-二醇产物。 3) Put the extract on a 200-300 mesh silica gel column, elute with a gradient of petroleum ether:ethyl acetate volume ratio of 70:1 to 1:1, combine the eluent with a volume ratio of 20:1 to 15:1, and evaporate to dryness naturally , 17(21)-Hoppene-6,12β-diol product was obtained by recrystallization.
提取率%=纯17(21)-何帕烯-6,12β-二醇重量/浸膏总量×100%=3.56%。 Extraction rate% = weight of pure 17(21)-hopaene-6,12β-diol/total amount of extract × 100%=3.56% .
对上述重结晶产物进行氢谱、碳谱分析,上述重结晶17(21)-何帕烯-6,12β-二醇的氢谱、碳谱见图1、图2,验证了该物质即为17(21)-何帕烯-6,12β-二醇。 The hydrogen spectrum and carbon spectrum analysis of the above-mentioned recrystallized product are carried out. The hydrogen spectrum and carbon spectrum of the above-mentioned recrystallized 17(21)-Hoppene-6,12β-diol are shown in Fig. 1 and Fig. 2, which proves that the substance is 17(21)-Hoppene-6,12β-diol.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210569717.9A CN103044515B (en) | 2012-12-25 | 2012-12-25 | A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210569717.9A CN103044515B (en) | 2012-12-25 | 2012-12-25 | A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103044515A CN103044515A (en) | 2013-04-17 |
CN103044515B true CN103044515B (en) | 2015-09-09 |
Family
ID=48057397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210569717.9A Expired - Fee Related CN103044515B (en) | 2012-12-25 | 2012-12-25 | A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103044515B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103305582B (en) * | 2013-06-25 | 2014-10-29 | 福建农林大学 | Method for extracting 17(21)-hopene-12beta-diol out of aschersonia |
CN103980334B (en) * | 2014-05-20 | 2016-01-13 | 东南大学 | A kind of compound and its preparation method and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772447A (en) * | 2012-08-15 | 2012-11-14 | 福建农林大学 | Method for extracting bacteriostatic agent from aschersoniaaleyrodis metabolin |
-
2012
- 2012-12-25 CN CN201210569717.9A patent/CN103044515B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772447A (en) * | 2012-08-15 | 2012-11-14 | 福建农林大学 | Method for extracting bacteriostatic agent from aschersoniaaleyrodis metabolin |
Non-Patent Citations (1)
Title |
---|
Hopane-Type Triterpenes and Binaphthopyrones from the Scale Insect Pathogenic Fungus Aschersonia paraphysata BCC 11964;Masahiko Isaka 等;《J. Nat. Prod.》;20100405;第73卷(第4期);第688-692页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103044515A (en) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102838650B (en) | Method of extracting dustanin from Moelleriella ochracea | |
CN103274915B (en) | Diterpenoid compounds libertellenone G and libertellenone H with antineoplastic activities and application thereof | |
CN112843026B (en) | Application of diphenyl ether compounds in the preparation of acetylcholinesterase inhibitors or drugs for the treatment of Alzheimer's disease | |
CN110218200A (en) | A kind of mangrove endogenetic fungus middle ring depsipeptide compound and the preparation method and application thereof | |
CN103044515B (en) | A kind of method extracting 17 (21)-hopenen-6,12 beta-diols from aschersonia aleyrodis | |
CN103739638B (en) | A kind of method of fermentable purifying tea saponin | |
CN104628680A (en) | Sesquiterpene lactone compounds with antibacterial activity and application thereof | |
CN103450320B (en) | A method for extracting hostanol from Mollerella ochrena | |
CN102329735B (en) | Method for preparing curvularin and indolizidine alkaloid and application | |
CN104894173B (en) | A kind of preparation method of curcumin derivate | |
CN104387396B (en) | Come from indole terpene speradine E and the application of aspergillus oryzae | |
CN103073527A (en) | Diterpene Libertellenone G and preparation method and use thereof | |
CN105441504B (en) | A kind of preparation method of CYCLIC DIPEPTIDES compounds | |
CN107805188B (en) | Biphenyl compound and preparation method and application thereof | |
CN103305582B (en) | Method for extracting 17(21)-hopene-12beta-diol out of aschersonia | |
CN113277999B (en) | Phthalide compound and preparation method and application thereof | |
CN102772447B (en) | A method for extracting bacteriostatic agent from the metabolites of A. whitefly | |
CN106047715A (en) | Nothapodytes pittosporoides endophyte trichoderma sp. strain and method thereof for extracting camptothecin | |
CN105384602A (en) | Patchoulicalcohol derivative and preparation method and application thereof | |
CN103290088B (en) | Method for extracting triterpenoid type substance, namely zeorin from moelleriella ochracea | |
CN101323606B (en) | Extraction and purification method of sesquiterpene coumarin ether and its application | |
CN102452916B (en) | A class of aromatic polyketones and their extraction methods and applications | |
CN103290089B (en) | A method for efficiently extracting 3β-acetyl-15α, 22-dihydroxyhopapadinone from Mollerella ochraceae | |
CN115433087B (en) | A method for extracting dibutyl terephthalate from Raffaelea lauricola | |
CN108658911B (en) | Furanonaquinone compound and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150909 Termination date: 20171225 |